SAN DIEGO, May 21, 2012 /PRNewswire/ -- Accelrys, Inc.
(NASDAQ: ACCL), a leading scientific enterprise R&D software
and services company, today announced a strategic content sourcing
collaboration with the Intellectual Property & Science division
of Thomson Reuters, the world's leading source of intelligent
information for businesses and professionals. Further expanding
Accelrys' dynamic partner network, the agreement accelerates
innovation, speeds time-to-market and improves the competitiveness
of pharmaceutical and biotech organizations by delivering relevant,
current and expertly curated life sciences content from Thomson
Reuters' Cortellis® for Informatics
via the scientifically aware Accelrys Enterprise Platform and
related Accelrys software offerings including Pipeline Pilot, Symyx
Notebook by Accelrys and Isentris.
To view the multimedia assets associated with this release,
please click
http://www.prnewswire.com/news-releases/accelrys-announces-strategic-collaboration-with-thomson-reuters-152113635.html
The Accelrys Enterprise Platform incorporates industry-leading
cheminformatics applications and tools that meet the end-to-end
needs of scientists to access, manage, analyze, report and share
scientific information in a unified environment that ensures
consistency, accuracy and completeness of the chemistry and
associated data being represented. This strong chemistry foundation
establishes Accelrys as the premier chemistry provider for Thomson
Reuters' publishing and web operations.
"We are pleased to be working with Accelrys and the Accelrys
Enterprise Platform to integrate information from Thomson
Reuters Cortellis," said Joseph
Donahue, senior vice president at Thomson Reuters. "Accelrys
is known for its strength in the scientific enterprise R&D
software and services market, and this partnership will offer more
options to our mutual customers to access, analyze and drive
actionable decisions from key content."
The Accelrys Enterprise Platform is the first scientifically
aware, service-oriented architecture that enables the integration
and deployment of broad scientific solutions across multiple
domains in the lab-to-plant process. Cortellis for
Informatics provides web services for investigational drugs,
drug targets, ontologies, patents, clinical trials and analytics in
biopharmaceutical R&D.
"Enabling life scientists to access Thomson Reuters
Cortellis content through a new Component Collection built on
the Accelrys Enterprise Platform will accelerate innovation by
providing actionable information to pharma and biotech
organizations," said Dr. Matt Hahn,
senior vice president and chief technology officer at Accelrys.
"Scientists gain convenient access to expertly refined content and
analysis tools through a single, user-friendly source delivered via
the most widely used integration platform in the life sciences
industry."
The Accelrys Partner Program enables industry collaborators to
combine their own products and services with Accelrys technologies
on a single, scientifically aware platform, reducing costs,
enhancing organizational efficiency, optimizing IT infrastructure
and improving innovation lifecycle management in new scientific
areas.
Beta testers at top-30 pharmaceutical companies are currently
assessing the new Thomson Reuters Component Collection on the
Accelrys Enterprise Platform. When beta testing is complete, this
new data sourcing solution from Accelrys and Thomson Reuters will
be generally available to organizations wishing to derive full
value from Thomson Reuters Cortellis content.
For more information, contact your Thomson Reuters or Accelrys
representative. You can also register for our jointly hosted
webinar, "The New Thomson Reuters Cortellis Collection for
Accelrys," to be held on Wednesday, May
23, 8:00 a.m. to 9:00 a.m. PDT.
About Accelrys, Inc.
Accelrys (NASDAQ:ACCL), a leading scientific enterprise
R&D software and services company, supports industries and
organizations that rely on scientific innovation to differentiate
themselves. The industry-leading Accelrys Enterprise Platform
provides a broad, flexible scientific solution optimized to
integrate the diversity of science, experimental processes and
information requirements across the research, development, process
scale-up and early manufacturing phases of product development. By
incorporating capabilities in applications for modeling and
simulation, enterprise lab management, workflow and automation, and
data management and informatics, Accelrys enables scientific
innovators to access, organize, analyze and share data in
unprecedented ways, ultimately enhancing innovation, improving
productivity and compliance, reducing costs and speeding time from
lab to market.
Accelrys solutions are used by more than 1,300 customers in the
pharmaceutical, biotechnology, energy, chemicals, aerospace,
consumer packaged goods and industrial products industries.
Headquartered in San Diego,
Calif., Accelrys employs more than 200 full-time PhD
scientists. For more information about Accelrys, visit
www.accelrys.com.
About Thomson Reuters
Thomson Reuters is the world's leading source of
intelligent information for businesses and professionals. We
combine industry expertise with innovative technology to deliver
critical information to leading decision makers in the financial
and risk, legal, tax and accounting, intellectual property and
science and media markets, powered by the world's most trusted news
organization. With headquarters in New
York and major operations in London and Eagan,
Minnesota, Thomson Reuters employs approximately 60,000
people and operates in over 100 countries. Thomson Reuters shares
are listed on the Toronto and New
York Stock Exchanges. For more information, go to
thomsonreuters.com.
Related Links:
Accelrys Website
About Scientific Innovation Lifecycle Management
SOURCE Accelrys, Inc.